BioStock article: Aptahem’s chief operating officer on the plans for 2021
2021-05-26
BioStock published an article on 26 May 2021 about Aptahem, which can be read in full below. The most anticipated milestone for sepsis company Aptahem is initiating first-in-human trials with candidate Apta-1, which is planned for next year. BioStock...
Read More